Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$498.29 - $574.41 $190,845 - $219,999
-383 Reduced 41.5%
540 $273,000
Q2 2023

Jul 21, 2023

SELL
$508.46 - $591.13 $178,469 - $207,486
-351 Reduced 27.55%
923 $481,000
Q1 2023

Apr 24, 2023

BUY
$535.0 - $604.82 $10,165 - $11,491
19 Added 1.51%
1,274 $734,000
Q4 2022

Mar 03, 2023

SELL
$484.71 - $571.37 $8,240 - $9,713
-17 Reduced 1.34%
1,255 $691,000
Q3 2022

Oct 25, 2022

BUY
$507.19 - $604.49 $4,564 - $5,440
9 Added 0.71%
1,272 $645,000
Q2 2022

Aug 01, 2022

BUY
$500.9 - $612.21 $40,572 - $49,589
81 Added 6.85%
1,263 $686,000
Q1 2022

May 02, 2022

BUY
$524.0 - $644.92 $6,812 - $8,383
13 Added 1.11%
1,182 $698,000
Q4 2021

Feb 04, 2022

BUY
$569.0 - $667.24 $39,830 - $46,706
70 Added 6.37%
1,169 $695,000
Q3 2021

Oct 20, 2021

BUY
$509.53 - $609.78 $27,514 - $32,928
54 Added 5.17%
1,099 $628,000
Q2 2021

Aug 09, 2021

BUY
$441.0 - $508.24 $74,088 - $85,384
168 Added 19.16%
1,045 $527,000
Q1 2021

Apr 27, 2021

BUY
$439.85 - $518.83 $157,906 - $186,259
359 Added 69.31%
877 $400,000
Q4 2020

Jan 25, 2021

BUY
$435.06 - $527.66 $225,361 - $273,327
518 New
518 $267,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Crumly & Associates Inc. Portfolio

Follow Crumly & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crumly & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crumly & Associates Inc. with notifications on news.